However, in routine clinical practice, breast cancer subtype is commonly approximated using the surrogate immunohistochemistry (IHC) markers, oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2(HER2) and Ki67 [4, 5]. This evidence concerns the gene ERBB2 and breast cancer.